Live feed07:00:00·2dPRReleasevia QuantisnowTEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpointsByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCHealth Care
